Abstract
The REDUCE-IT trial demonstrated that icosapent ethyl, an ethyl ester of eicosapen-taenoic acid (EPA), reduced cardiovascular events in an at-risk pop......
小提示:本篇文献需要登录阅读全文,点击跳转登录